Healius LimitedASX: HLS

Strategy Day Presentation

· MarketScreener

rsonale use nlyo

20 May 2022

Healius Strategy Day

use only

ersonal

2

Healius Strategy Day

Acknowledgement of country

We acknowledge the Gadigal People of the Eora Nation as the traditional custodians of the land on which we gather today, and pay our respects to their Elders - past, present and emerging

COVID collection moving to regular ACCs from dedicated drive-throughs
Growth in requests for testing of other respiratory viruses along with COVID - expected to continue through the winter

Trading update

Core businesses

• Revenues in all divisions slowly trending up, but not yet returned to normal with

impacts from floods and extensive COVID / isolation requirements in every state

• Q3 Pathology slightly ahead of Medicare data (as in the first half) and Imaging

also slightly ahead

• Operational challenges and additional costs due to level of COVID infections e.g.

staff on sick leave, last-minute cancellations of surgery and imaging procedures

only

•

Expect demand to catch up to long-term trends with population growth, ageing

population, increasing p

•

revalence of chronic diseases and better survival rates. Also backlog in routine

Agilex's new large molecule laboratory, South Australia

services and known underdiagnosis of diseases

COVID-19 Pathology

use

•

After a strong January, COVID testing around 15k per working day through

February to April1 (as expected at 1H22 results)

ersonal

•

•

1 Working day calculation based on total revenue / number of working days. April has similar working day volumes to Feb-Mar but less total revenue with only 18 working days in the month

3 Healius Strategy Day

Long term growth trends and COVID impact

use only

ersonal

Historical growth trend

4

Healius Strategy Day

Healius investment proposition

Well positioned in attractive markets

only

Solid core market fundamentals

Scaled diagnostics operator

Defensible incumbent positions

use

Clear operating leverage

Double-digit ROIC growth opportunities

Early positions in emerging diagnostics (e.g. genomics)

ersonal

5

Healius Strategy Day

Ready to capture growth & create value

  • Ability to consolidate & integrate for network growth
  • Cost out track record
  • Compelling digital proposition and strategy
  • Customer-centricre-orientation
  • Balance sheet strength
  • Proven commitment to TSR

This is an excerpt of the original content. To continue reading it, access the original document here.